William Blair initiated coverage of Cardinal Health with a rating of Outperform
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/28/2026 | Outperform | William Blair | |
| 1/9/2026 | Neutral → Buy | Citigroup | |
| 12/9/2025 | $243.00 | Overweight | Barclays |
| 6/3/2025 | $179.00 | Equal Weight → Overweight | Wells Fargo |
| 2/5/2025 | $140.00 → $150.00 | Hold → Buy | Jefferies |
| 1/8/2025 | $130.00 → $144.00 | Hold → Buy | TD Cowen |
| 1/7/2025 | $140.00 | In-line → Outperform | Evercore ISI |
| 1/6/2025 | $132.00 → $145.00 | Neutral → Buy | BofA Securities |
William Blair initiated coverage of Cardinal Health with a rating of Outperform
Citigroup upgraded Cardinal Health from Neutral to Buy
Barclays initiated coverage of Cardinal Health with a rating of Overweight and set a new price target of $243.00
DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy. Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology. Combined, the transactions total approximately $360 million in cash, subject to working capital adjustments."These strategic transactions build on the synergies created by our recent investments in home care," said Jason Hollar, Chief Executive Officer, C
Veteran physician executive and former Solaris Health CEO to lead one of the nation's largest cardiology platformsNASHVILLE, Tenn., July 14, 2026 /PRNewswire/ -- Cardiovascular Logistics ("CVL" or the "Company"), one of the nation's leading cardiology management services organizations, today announced the appointment of Gary M. Kirsh, M.D. as Chief Executive Officer, effective immediately. Dr. Kirsh has served on CVL's Board of Directors since November 2025 and brings more than three decades of experience building and leading large, physician-led specialty platforms. Dr. Kirsh is the co-founder and former Chief Executive Officer of Solaris Health, which he built into the largest urology mana
DUBLIN, Ohio, July 9, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2026 on August 11, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months.About Cardinal Health
4 - CARDINAL HEALTH INC (0000721371) (Issuer)
4 - CARDINAL HEALTH INC (0000721371) (Issuer)
4 - CARDINAL HEALTH INC (0000721371) (Issuer)
11-K - CARDINAL HEALTH INC (0000721371) (Filer)
11-K - CARDINAL HEALTH INC (0000721371) (Filer)
SD - CARDINAL HEALTH INC (0000721371) (Filer)
Veteran physician executive and former Solaris Health CEO to lead one of the nation's largest cardiology platformsNASHVILLE, Tenn., July 14, 2026 /PRNewswire/ -- Cardiovascular Logistics ("CVL" or the "Company"), one of the nation's leading cardiology management services organizations, today announced the appointment of Gary M. Kirsh, M.D. as Chief Executive Officer, effective immediately. Dr. Kirsh has served on CVL's Board of Directors since November 2025 and brings more than three decades of experience building and leading large, physician-led specialty platforms. Dr. Kirsh is the co-founder and former Chief Executive Officer of Solaris Health, which he built into the largest urology mana
DUBLIN, Ohio, March 23, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B. Kenny as Chair of the Board following Mr. Kenny's retirement, effective immediately. Mr. Kenny has served on the Board since 2007 and as Chairman since 2018. During his tenure on the Board, Mr. Kenny supported the Company through periods of significant transformation, including strategic portfolio evolution and operational improvement initiatives."On behalf of the Board and our management team, we are d
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv
DUBLIN, Ohio, May 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2026 to shareholders of record at the close of business on July 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an opera
Revenue increased 11% to $60.9 billionGAAP1 operating earnings decreased 30% to $509 million; GAAP diluted EPS decreased 20% to $1.69Non-GAAP operating earnings increased 18% to $956 million; non-GAAP diluted EPS increased 35% to $3.17Cardinal Health raises and narrows fiscal year 2026 non-GAAP EPS guidance2 to $10.70 to $10.80Cardinal Health reduces debt and completes additional $250 million share repurchase, bringing FY26 repurchase total to $1.0 billionDUBLIN, Ohio, April 30, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025.Third quarter GAAP operating earn
DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc
SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)
SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)
SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)